Home / Top News / Progenity to Present Key Prospective Verification Study Data for its Preeclampsia Rule-Out Test at 2021 American College of Obstetricians and Gynecologists Annual Meeting
Progenity to Present Key Prospective Verification Study Data for its Preeclampsia Rule-Out Test at 2021 American College of Obstetricians and Gynecologists Annual Meeting
SAN DIEGO, April 08, 2021 (GLOBE NEWSWIRE) Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing products in women’s health, will be presenting verification study data for its Preecludia™ rule-out test for preeclampsia at the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting set to take place April 30 – May 2, 2021.
ビットコイン急落、テスラ株やETFに波及
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
カナダ当局、世界初となるビットコインETFの発行承認
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
ゲームストップ株急騰、恩恵受けたファンドはごく一部
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
今年の米ファンド、運用成績トップはテック株と仮想通貨関連
newsweekjapan.jp - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsweekjapan.jp Daily Mail and Mail on Sunday newspapers.